Chapter 2
The Buchanan Biopharma conference room was designed to intimidate.
I recognized the technique because I’d watched Roland deploy it for five years — the long walnut table, the high-backed chairs, the windows positioned so the light fell on the board members and the presenters sat with the sun in their eyes.
Even the water glasses were heavy crystal, placed at exact intervals, like props in a play about power.
I sat in the third chair on the left and made sure my posture said nothing.
It was nine a.m. on Monday, four days after the reception.
Priya Nair stood at the head of the table with a clicker in one hand and a printed agenda in the other, walking the five finalists through the next six weeks of our lives.
The board — seven members, including Liam — sat along the opposite side.
Dr. Martin Hale anchored the center, flanked by a woman I didn’t recognize and a man with the particular tan that came from a recent golf trip.
Liam sat two seats from the end. He’d chosen the position deliberately, I was sure of it.
Far enough that we wouldn’t have to make conversation.
Close enough that every time I looked at the board, he was there.
I didn’t look at him. I looked at Priya’s slides.
“Each session has a different format,” she was saying. “Today is your orientation — you’ll each give a brief overview of your research, five minutes maximum, followed by questions from the panel. Think of it as a conversation, not a defense.”
It was absolutely a defense. Everyone in the room knew that.
The Hopkins neurologist — Dr. Warren Cho — was already arranging his notes with the precision of a man who’d been through tenure review.
The immunologist couple from Chicago, Drs.
Arun and Meera Prakash, sat shoulder to shoulder, radiating the calm of people who had each other’s backs.
Joanna Voss caught my eye from the far end and mimed shooting herself in the head.
I bit the inside of my cheek to keep from smiling.
I was second to present. Dr. Cho went first — a polished ten minutes that he compressed to five with the efficiency of someone who had been giving the same talk for thirty years.
His work was solid, important, and the kind of incremental progress that large institutions loved to fund because it confirmed what they already believed.
Then me. I stood, smoothed my blazer, and walked to the screen.
I didn’t need notes. I’d lived inside this research for twelve months.
Every data point, every correlation, every late night cross-referencing IL-6 response patterns against autoimmune onset windows — it was in me the way muscle memory was in an athlete.
I’d built this work in the wreckage of my marriage, and it was mine in a way nothing in my life had ever been mine before.
“Inflammatory biomarker panels,” I began. “Specifically, the predictive window between cytokine cascades and autoimmune symptom onset. Most current diagnostics catch the fire after it’s burning. My team is working on catching the smoke.”
I walked them through it. The methodology, the preliminary data, the three published papers that had gotten me on this shortlist. I kept it clean and direct — no jargon for jargon’s sake, no hedging, no academic throat-clearing.
I spoke to the board the way I spoke to my team: like intelligent people who deserved to be talked to, not performed for.
Hale asked two questions, both sharp and informed. The woman next to him — Dr. Carolyn Metz, I learned from her nameplate — asked a third about scalability that showed she’d actually read the submission. I answered all three without hesitating.
The one person who didn’t ask a question was Liam.
He sat two seats from the end with his hands folded on the table and his eyes on me and he said nothing.
His attention had the weight of humidity — present everywhere, impossible to identify in any single direction.
But he didn’t speak. He didn’t lean in. He didn’t do any of the things the old Liam would have done — no pointed question to show the room he was smart, no comment designed to steer the conversation, no subtle flex of the authority his family name bought him at this table.
He just listened. And when I finished, he nodded once. A small movement. Almost imperceptible if you weren’t the person it was aimed at.
I wasn’t going to be the person it was aimed at.
I sat down. The Prakashes presented next — seamless, united, finishing each other’s sentences the way they had at the reception.
Joanna went last, nervous and brilliant, stumbling once over a slide transition but recovering with a joke about machine learning models being smarter than her that got a genuine laugh from Hale.
She was good. They were all good. The grant was going to be a real fight, and for the first time in years, I wanted to win something that had nothing to do with surviving.
The session broke at eleven. Priya reminded everyone that Session Two — the lab tours — was in ten days, and that we’d receive individual scheduling by email.
The board members stood, stretched, broke into clusters.
Someone had set up coffee and pastries on a side table, and the room reorganized itself into the loose choreography of people networking.
I poured a cup of black coffee and positioned myself near the windows, where the light made it hard for anyone approaching to see my expression. A small advantage. I’d learned to collect small advantages.
Dr. Metz found me. She was in her late fifties, silver-streaked hair pulled into a clean knot, the kind of woman who had fought for every inch of her career and carried it in her posture.
“Your IL-6 correlation work,” she said, without preamble. “You’re seeing the pattern in pediatric populations too?”
“We’re starting to. The preliminary numbers are promising, but the cohort is small. That’s part of what the grant would fund — expanding the pediatric arm.”
“Good.” She said it like a verdict. “The pediatric application is what will get this funded. Don’t bury it behind the adult data.”
“I won’t. Thank you.”
She nodded and moved on, and I stood there for a moment absorbing the fact that a board member had just given me unsolicited strategic advice. Either she liked my work, or she was the kind of person who couldn’t help mentoring younger women in the field. Either way, I’d take it.
The coffee was bitter and I was deciding whether to eat a croissant I didn’t want when the air shifted. That same pressure change from the reception, the specific quality of awareness that meant he was close.
“Dr. Keating.”
Professional. Formal. The name he’d started using at the reception.
I turned and there he was, two feet away, holding a cup of coffee he wasn’t drinking and wearing an expression I’d never seen on him before.
It took me a moment to place it because Liam Buchanan had never worn it in the five years I’d known him.
Uncertainty.
“Mr. Buchanan.” I matched his formality. Mr., not Liam. A wall built of syllables.
“Your presentation was excellent. The IL-6 correlation work is — the methodology is rigorous. You should be proud.”
“I am.”
He was quiet for a beat. Around us, the room buzzed. Cho was deep in conversation with Hale. The Prakashes were talking to Priya. Nobody was watching us. That made it worse, somehow. If we’d had an audience, the performance would have been easier.
“Hallie, I know you said—”
“I said there’s nothing to discuss. That hasn’t changed in four days.”
“I’m not trying to discuss anything. I just —” He stopped.
Reset. Tried again with the careful deliberation of a man defusing something.
“I want you to know that I’m recusing myself from the final vote.
I’ve already told Hale. I don’t want my presence on this board to affect your chances in any direction. ”
That stopped me. Not because it was generous — I didn’t want his generosity — but because the old Liam would never have voluntarily surrendered influence. Influence was currency, and Buchanans didn’t give away currency. They invested it.
“Thank you,” I said, because it was the correct thing to say.
“It’s the right thing to do.”
“Yes, it is.”
Another silence. He was working up to something.
I could see it building behind his eyes — the same look he’d had in his office when I walked in fifteen months ago and he’d said my name in that broken voice and I’d known, in the two seconds before the rest of the picture assembled, that something was already over.
“Hallie—”
“Stop.” I set my coffee down on the window ledge.
My hands were steady. I’d practiced this — not the words, but the steadiness.
The refusal to shake in front of him. “I’m going to say this once, and then we’re done.
You don’t get to stand in this conference room and say my name like it still belongs to you.
It doesn’t. You cheated on me. You had a woman in your office, on our couch — the couch where we drank champagne from paper cups the day you moved in.
You looked me in the eye for three weeks after it started and you lied every single time.
When I confronted you, the first thing out of your mouth was ‘it didn’t mean anything,’ like that was supposed to help.
Like the fact that you destroyed our marriage for something meaningless was better than destroying it for something real. ”
His face had gone still. Not blank — there was too much behind it for blank. But still, like a lake before something breaks the surface.
“I know,” he said.